Genetic Susceptibility and Immunological Synapse in Type 1 Diabetes and Thyroid Autoimmune Disease[1]

Abstract

Type 1 diabetes mellitus results from an immune mediated or idiopathic destruction of the pancreatic beta cells. Its aetiopathogenesis remains to be elucidated, despite great progress in the characterisation of beta-cell antigens, T-lymphocyte and antibody markers as well as whole genome screening. The incidence of type 1 diabetes is rising in most countries. Moreover, a considerable proportion of patients initially presenting with type 2 diabetes mellitus have an underlying type 1 diabetes with a latent course. A proportion of type 1 diabetes patients have concomittant thyroid autoimmune disease, either Hashimoto's thyroiditis or Graves' disease. Whereas Hashimoto's thyroiditis shares the same destructive immune process as type 1 diabetes, Graves' disease is unique in stimulating specifically the TSH-receptor through high-affinity immunoglobulins. However, both the thyroid autoimmune disorders and type 1 diabetes have susceptibility genes in common, implying shared pathways of immunopathogenesis. It has become clear that the genetic composition of a host at least partly determines the course of an immune response leading either to an organ-specific autoimmune disease or creating a state of balance where antibodies are hallmarks of (auto)immunity but normal function prevails. Genetic factors including MHC (IDDM 1-genetic locus) and non-MHC genes (IDDM 2 - IDDM X) have been shown to determine susceptibility to autoimmunity in type 1 diabetes or lifelong tolerance. Currently the importance of the various diabetes associated genes is becoming clearer due to functional studies. Our review attempts to compile the relevant data that have accumulated in recent years and offers perspectives for prediction, prevention and possibly even therapy of immune-mediated endocrinopathies.

Autoimmunity - HLA - immunogenetics - immunological synapse - type 1 diabetes

References

• 1 Arif S, Tree T I, Astill T P, Tremble J M, Bishop A J, Dayan C M, Roep B O, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.  J Clin Invest. 2004;  113 451-463
• 2 Baur M P, Fimmers R, Fritsche C, Hümmelink M, Neugebauer M, Acton R T, Hodge T, Barbosa J, Bertrams J, Fehsel K, Kolb H, Rothe H, Boehm B, Cambon-Thomsen A, Avoustin P, Coppin H, Darnaud J, Massabie P, Ohayon E, De Preval C, Tauber J P, Thomsen M, Colle E, MacDonald M J, Nevin D, Gottschall H, Nepom G T, Robinson D M, Holbeck S, Palmer J P, Nerup J, Rotter J I, Vadheim C, Rittner C, Schneider P, Sheehy M J, Cox N J, Baker L, Spielman R S. Genetic analysis of IDDM: The GAW5 multiplex family dataset.  Genetic Epidemiology. 1989;  6 15-20
• 3 Bennett S T, Lucassen A M, Gough S CL, Powell E E, Undlien D E, Pritchard L E, Merriman M E, Kawaguchi Y, Dronsfield M J, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen K S, Barnett A H, Bain S C, Todd J A. Susceptibility to human type 1 diabetes at IDDM 2 is determined by tandem repeat variation at the insulin gene minisatellite locus.  Nature Genetics. 1995;  9 284-292
• 4 Boehm B O, Manfras B, Seissler J, Schoeffling K, Glueck M, Holzberger G, Seidl S, Kuehnl P, Trucco M, Scherbaum W A. Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren: Ulm-Frankfurt population study.  Diabetes. 1991 a;  40 1435-1439
• 5 Boehm B O, Seißler J, Glueck M, Manfras B J, Thomas H, Schmidt K, Rudert W A, Usadel K H, Trucco M, Scherbaum W A. The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQβ chain.  Dis Markers. 1991 b;  9 273-280
• 6 Braun J, Donner H, Siegmund T, Walfish P G, Usadel K H, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.  Tissue Antigens. 1998;  51 563-566
• 7 Bromley S K, Burack W R, Johnson K G, Somersalo K, Sims T N, Sumen C, Davis M M, Shaw A S, Allen P M, Dustin M L. The immunological synapse.  Annu Rev Immunol. 2001;  19 375-396
• 8 Concannon P, Gogolin-Ewens K J, Hinds D A, Wapelhorst B, Morrison V A, Stirling B, Mitra M, Farmer J, Williams S R, Cox N J, Bell G I, Risch N, Spielman R S. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus.  Nature Genetics. 1998;  19 292-296
• 9 Corper A L, Stratmann T, Apostolopoulos V, Scott C A, Garcia K C, Kang A S, Wilson I A, Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.  Science. 2000;  288 505-511
• 10 Cox N J, Wapelhorst B, Morrison V A, Johnson L, Pinchuk L, Spielman R S, Todd J A, Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.  Am J Hum Genet. 2001;  69 820-830
• 11 Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain S C, Barnett A H, Todd J A. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.  Hum Mol Genet. 2001;  10 2025-2037
• 12 Cudworth A G, Woodrow J C. Evidence for HL-A-linked genes in “juvenile” diabetes mellitus.  Br Med J. 1975;  3 133-135
• 13 Curtsinger J M, Schmidt C S, Mondino A, Lins D C, Kedl R M, Jenkins M K, Mescher M F. Inflammatory cytokines provide a third signal for activation of naive CD4 + and CD8 + T cells.  J Immunol. 1999;  162 3256-3262
• 14 Davies J L, Kawaguchi Y, Bennett S T, Copeman J B, Cordell H J, Pritchard L E, Reed P W, Gough S CL, Jenkins S C, Palmer S M, Balfour K M, Rowe B R, Farrall M, Barnett A H, Bain S C, Todd J A. A genome-wide search for human type 1 diabetes susceptibility genes.  Nature. 1994;  371 130-136
• 15 De Oliveira D B, Harfouch-Hammoud E, Otto H, Papandreou N A, Stern L J, Cohen H, Boehm B O, Bach J, Caillat-Zucman S, Walk T, Jung G, Eliopoulos E, Papadopoulos G K, van Endert P M. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.  Mol Immunol. 2000;  37 813-825
• 16 Delon J, Germain R N. Information transfer at the immunological synapse.  Curr Biol. 2000;  10 R923-933
• 17 Demotz S, Grey H M, Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation.  Science. 1990;  249 1028-1030
• 18 Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.  Nat Med. 1999;  5 1365-1369
• 19 Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish P G, Usadel K H, Badenhoop K. Codon 17 polymorphism of the CTLA4 gene in Hashimoto's thyroiditis and Addison's disease.  J Clin Endocrino Metab. 1997 a;  82 4130-4132
• 20 Donner H, Rau H, Walfish P G, Braun J, Siegmund T, Finke R, Usadel K H, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.  J Clin Endocrinol Metab. 1997 b;  82 143-146
• 21 Durinovic-Bello I, Riedl M, Rosinger S, Maisel N, Kalbacher H, Deeg M, Neckermann J, Schreckling H-J, Schlosser M, Ziegler M, Kuehnl P, Boehm B O. Th2 dominance of T helper cell response to preproinsulin in individuals with preclinical type 1 diabetes.  Annals New York Academy Sciences. 2002 a;  958 209-213
• 22 Durinovic-Bello I, Boehm B O, Ziegler A-G. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.  J Autoimmunity. 2002 b;  18 55-66
• 23 Durinovic-Bello I, Maisel N, Schlosser M, Kalbacher H, Deeg M, Eiermann T, Karges W, Boehm B O. Relationship between T and B cell responses to proinsulin in human type 1 diabetes.  Ann NY Acad Sci USA. 2003;  1005 288-294
• 24 Durinovic-Bello I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliot J, Roep B O, Boehm B O. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.  Diabetologia. 2004;  47 439-450
• 25 Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur M P. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families.  Genetic Epidemiology. 1989;  6 107-112
• 26 French M B, Allison J, Cram D S, Thomas H E, Dempsey-Collier M, Silva A, Georgiou H M, Kay T W, Harrison L C, Lew A M. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.  Diabetes. 1997;  46 34-39
• 27 Gao W, Demirci G, Li X C. Negative T cell costimulation and islet tolerance.  Diabetes Metab Res Rev. 2003;  19 179-185
• 28 Gorsuch A N, Spencer K M, Lister J, Wolf E, Bottazzo G F, Cudworth A G. Can future type I diabetes be predicted? A study in families of affected children.  Diabetes. 1982;  31 862-866
• 29 Grakoui A, Bromley S K, Sumen C, Davis M M, Shaw A S, Allen P M, Dustin M L. The immunological synapse: a molecular machine controlling T cell activation.  Science. 1999;  285 221-227
• 30 Guerkov R EM, Targoni O S, Kreher C R, Boehm B O, Herrera M T, Tary-Lehmann M, Lehmann P V, Schwander S K. Detection of low frequency antigen-specific IL-10-producing CD4 + T cells via ELISPOT in PBMC: Cognate vs. non-specific production of the cytokine.  J Immunol Methods. 2003;  279 111-121
• 31 Harding C V, Unanue E R. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.  Nature. 1990;  346 574-576
• 32 Hashimoto L, Habita C, Beressi J P, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter J I, Djoulah S, James M R, Froguel P, Weissenbach J, Lathrop G M, Julier C. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11 q.  Nature. 1994;  371 161-164
• 33 Hesse M D, Karulin A Y, Boehm B O, Lehmann P V, Tary-Lehmann M. A T-cell clone's avidity is a function of its activation state.  J Immunol. 2001;  167 1353-1361
• 34 Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells.  Immunity. 1998;  8 89-95
• 35 Jury K M, Loeffler D, Eiermann T H, Ziegler B, Boehm B O, Richter W. Evidence for somatic mutation and affinity maturation of diabetes associated human autoantibodies to glutamate decarboxylase.  J Autoimmun. 1996;  9 371-377
• 36 Karges W, Pechhold K, Al Dahouk S, Riegger I, Rief M, Wissmann A, Schirmbeck R, Barth C, Boehm B O. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in NOD and in RIP-B7. 1 mice.  Diabetes. 2002;  51 3237-3244
• 37 Karges B, Durinovic-Bello I, Heinze E, Boehm B O, Debatin K-M, Karges W. Complete long-term recovery of beta cell function in autoimmune Type 1 diabetes following insulin treatment.  Diabetes Care. 2004;  27 1207-1208
• 38 Katz J D, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis.  Cell. 1993;  74 1089-1100
• 39 Klehmet J, Shive C, Guardia-Wolff R, Petersen I, Spack E G, Boehm B O, Weissert R, Forsthuber T G. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.  Clin Immunol. 2004;  111 53-60
• 40 Kolb H. .  Benign versus destructive insulitis Diabetes Metab Rev. 1997;  13 139-146
• 41 Kreher C R, Dittrich M T, Guerkov R, Boehm B O, Tary-Lehmann M. CD4 + and CD8 + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISA assays.  J Immunol Methods. 2003;  278 79-93
• 42 Kremer J M, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah I F, Williams G R, Becker J C, Hagerty D T, Moreland L W. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.  N Engl J Med. 2003;  349 1907-1915
• 43 Lampeter E F, Homberg M, Quabeck K, Schaefer U W, Wernet P, Bertrams J, Grosse-Wilde H, Gries F A, Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation.  Lancet. 1993;  341 1243-1244
• 44 Lee K H, Wucherpfennig K W, Wiley D C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.  Nat Immunol. 2001;  2 501-507
• 45 Lee K H, Holdorf A D, Dustin M L, Chan A C, Allen P M, Shaw A S. T cell receptor signaling precedes immunological synapse formation.  Science. 2002;  295 1539-1542
• 46 Lehmann P V, Sercarz E E, Forsthuber T, Dayan C M, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire.  Immunol Today. 1993;  14 203-208
• 47 Li H, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.  J Clin Endocrinol Metabolism. 2001;  86 574-582
• 48 Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum W A, Kolb H, Noordzij J G, Roep B O. Development of type 1 diabetes despite severe hereditary B-cell deficiency.  N Engl J Med. 2001;  345 1036-1040
• 49 McDevitt H. Closing in on Type 1 diabetes.  N Engl J Med. 2001;  345 1060-1061
• 50 Mein C A, Esposito L, Dunn M G, Johnson G CL, Timms A E, Goy J V, Smith A N, Sebag-Montefiore L, Merriman M E, Wilson A J, Pritchard L E, Cucca F, Barnett A H, Bain S C, Todd J A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom.  Nature Genetics. 1998;  19 297-300
• 51 Morel P A, Dorman J S, Todd J A, McDevitt H O, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.  Proc Natl Acad Sci USA. 1988;  86 8111-8115
• 52 Nerup J, Platz P, Andersen O O, Christy M, Lyngsoe J, Poulsen J E, Ryder L P, Nielsen L S, Thomsen M, Svejgaard A. HLA antigens and diabetes mellitus.  Lancet. 1974;  2 864-866
• 53 Ott P A, Dittrich M T, Herzog B A, Guerkov R, Gottlieb P A, Putnam A L, Durinovic-Bello I, Boehm B O, Tary-Lehmann M, Lehmann P V. T-cells recognize multiple GAD65 and proinsulin epitopes in human Type 1 diabetes, suggesting determinant spreading.  J Clin Immunol. 2004;  24 327-339
• 54 Pani M A, Van Autreve J, Van Der Auwera B J, Gorus F K, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.  Diabetologia. 2002;  45 1340-1343
• 55 Peakman M, Tree T I, Endl J, van Endert P, Atkinson M A, Roep B O. Second International Immunology of Diabetes Society Workshop for Standardization of T-Cell Assays in Type 1 Diabetes. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-Cell Assays in Type 1 Diabetes.  Diabetes. 2001;  50 1749-1754
• 56 Pechhold K, Patterson N B, Blum C, Fleischacker C L, Boehm B O, Haralan D M. Low dose streptozotocin induced diabetes in rat insulin promotor (RIP)-mCD80 transgenic mice is T cell autoantigen-specific and CD28 dependent.  J Immunol. 2001;  166 2531-2539
• 57 Pechhold K, Karges W, Boehm B O, Harlan D M. Beta cell-specific CD80 (B7 - 1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes.  J Autoimmun. 2003;  20 1-13
• 58 Pociot F, Karlsen A E, Pedersen C B, Aalund M, Nerup J. Novel analytical methods applied to type 1 diabetes genome-scan data.  Am J Hum Genet. 2004;  74 647-660
• 59 Pociot F, McDermott M F. Genetics of type 1 diabetes mellitus.  Genes Immu. 2002;  3 235-249
• 60 Pugliese A, Zeller M, Fernandez Jr A, Zalcberg L J, Bartlett R J, Ricordi C, Pietropaolo M, Eisenbarth G S, Bennett S T, Dhavalkumar D P. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes.  Nature Genetics. 1997;  15 293-297
• 61 Reay P A, Matsui K, Haase K, Wülfing C, Chien Y H, Davis M M. Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies.  J Immunol. 2000;  164 5626-5632
• 62 Richter W, Mertens T, Schoel B, Muir P, Ritzkowsky A, Scherbaum W A, Boehm B O. Sequence homology of the diabetes associated autoantigen glutamate decarboxylase with coxsackie B4 - 2 C protein and heat shock protein 60 mediates no molecular mimikry of autoantibodies.  J Exp Med. 1994;  180 721-726
• 63 Richter W, Jury K M, Loeffler D, Manfras B J, Eiermann T H, Boehm B O. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen driven immune response to glutamic acid decarboxylase in type I diabetes mellitus.  Eur J Immunol. 1995;  25 1703-1712
• 64 Rininsland F H, Helms T, Asaad R J, Boehm B O, Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity.  J Immunol Method. 2000;  240 143-155
• 65 Rothe H, Jenkins N A, Copeland N G, Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.  J Clin Invest. 1997;  99 469-74
• 66 Salomon B, Bluestone J A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.  Annu Rev Immunol. 2001;  19 225-252
• 67 Seidl C, Donner H, Fischer B, Usadel K H, Seifried E, Kaltwasser P, Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis.  Tissue Antigens. 1998;  51 62-66
• 68 Shahinian A, Pfeffer K, Lee K P, Kundig T M, Kishihara K, Wakeham A, Kawai K, Ohashi P S, Thompson C B, Mak T W. Differential T cell costimulatory requirements in CD28-deficient mice.  Science. 1993;  261 609-612
• 69 Targoni O S, Baus J, Hofstetter H H, Hesse M D, Karulin A Y, Boehm B O, Forsthuber T G, Lehmann P V. Frequencies of neuroantigen-specific T cells in the central nervous system the immune periphery during the course of experimental allergic encephalomyelitis.  J Immunol. 2001;  166 4757-4764
• 70 Todd J A, Wicker L S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models.  Immunity. 2001;  15 387-395
• 71 Trowsdale J, Parham P. Mini-review: defense strategies and immunity-related genes.  Eur J Immunol. 2004;  34 7-17
• 72 Ueda H, Howson J M, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow D B, Hunter K M, Smith A N, Di Genova G, Herr M H, Dahlman I, Payne F, Smyth D, Lowe C, Twells R C, Howlett S, Healy B, Nutland S, Rance H E, Everett V, Smink L J, Lam A C, Cordell H J, Walker N M, Bordin C, Hulme J, Motzo C, Cucca F, Hess J F, Metzker M L, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie K M, Undlien D E, Ronningen K S, Guja C, Ionescu-Tirgoviste C, Savage D A, Maxwell A P, Carson D J, Patterson C C, Franklyn J A, Clayton D G, Peterson L B, Wicker L S, Todd J A, Gough S C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.  Nature. 2003;  423 506-511
• 73 Unanue E R. Antigen-presenting function of the macrophage.  Annu Rev Immunol. 1984;  2 395-428
• 74 Waldner H, Collins M, Kuchroo V K. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease.  J Clin Invest. 2004;  113 990-997
• 75 Wicker L S, Miller B J, Chai A, Terada M, Mullen Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells: transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.  J Exp Med. 1988;  167 1801-1810
• 76 Williams C B, Engle D L, Kersh G J, Michael White J, Allen P M. A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex.  J Exp Med. 1999;  189 1531-1544
• 77 Yang M, Charlton B, Gautam A M. Development of insulitis and diabetes in B cell-deficient NOD mice.  J Autoimmun. 1997;  10 257-260
• 78 Zavattari P, Lampis R, Mulargia A, Loddo M, Angius E, Todd J A, Cucca F. Confirmation of the DRB1-DQB1 loci as the major component of IDDM 1 in the isolated founder population of Sardinia.  Human Molecular Genetics. 2000;  9 2967-2972
• 79 Zerbib A, Molvig J, Thomsen M, Coppin H, Cambon-Thomsen A, Sommer E, Nerup J, De Préval C. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.  Disease Markers. 1989;  7 27-41

1 This review is decicated to Klaus H. Usadel on the occasion of his 65th birthday.